Genmab Announces Appeal of US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit

Source :: GlobeNewswire. December 6, 2011
Publication Year :: 2011
Abstract: Byline: Staff COPENHAGEN, Denmark, Dec 6, 2011 (GlobeNewswire via COMTEX) -- Genmab A/S (Copenhagen:GEN) announced today that Genentech and Biogen Idec have appealed the judgment in favor of GlaxoSmithKline (GSK) [...]

Subjects :: Genentech Inc. -- Intellectual property
Genmab A/S -- Intellectual property
Biological products industry -- Intellectual property
Patent infringement
Pharmaceutical industry -- Intellectual property
Banking, finance and accounting industries
Business
Arzerra (Medication)

Tools